mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
7e-06 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
8e-06 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
9e-06 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |